BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs7903146
,
SNCA
,
cell-cell adhesion
,
Ischemia
,
Stem cell
,
Pharmacogenetics
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
kinase inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Target Hopping from Protein Kinases to PXR: Identification of Small-Molecule Protein Kinase Inhibito…
Current developments in extracellular-regulated protein kinase (ERK1/2) inhibitors.
CHOP Increases TRIB3-Dependent miR-208 Expression to Potentiate Vascular Smooth Muscle Cell Prolifer…
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degrada…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Identification of PAthways of Kinase Inhibitors TOxicity
Tumor Kinase Inhibitor Concentrations Measured by PET
A Study to Evaluate Effectiveness and Safety of Tyrosine Kinase Inhibitors
Effects of Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
Determination of Intratumoral Concentrations of Kinase Inhibitors in Patients With Advanced Solid Ma…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ